申请人:Imperial College of Science, Technology and Medicine
公开号:US05281587A1
公开(公告)日:1994-01-25
The present invention provides pharmaceutical preparations for the treatment of estrogen dependent tumors. The pharmaceutical preparations contain an effective amount of a steroid sulphatase inhibitor of the formula: ##STR1## where R is alkyl, preferably C.sub.1 -C.sub.6 alkyl, and the ring system A B C D is a steroid nucleus selected from the group consisting of oestrone, dehydroepiandrosterone, substituted oestrones and substituted dehydroepiandrosterones or pharmaceutically acceptable salts thereof.
Tacke; Strecker; Niedner, Liebigs Annalen der Chemie, 1981, vol. No. 3, # 3, p. 387 - 395
作者:Tacke、Strecker、Niedner
DOI:——
日期:——
Stereoselective and chemoselective oxidation of phosphorothionates using MMPP
作者:John A. Jackson、Clifford E. Berkman、Charles M. Thompson
DOI:10.1016/s0040-4039(00)60006-0
日期:1992.10
MMPP (monoperoxyphthalic acid, magnesium salt) converts phosphorothionates to the corresponding oxons in good yield with excellent chemoselectivity and stereoselectivity.
Methanolysis of phosphoramidates with boron trifluoride-methanol complex
作者:Seungmin Ryu、John A. Jackson、Charles M. Thompson
DOI:10.1021/jo00016a042
日期:1991.8
Bel'skii,V.E. et al., Journal of general chemistry of the USSR, 1969, vol. 39, # 1, p. 167 - 170